BBT001 in Healthy Volunteers and in Adult Patients with Atopic Dermatitis
This research is looking into a new treatment called BBT001 for a skin condition called atopic dermatitis, also known as eczema. This is a very early stage (Phase 1) study, which means it's one of the first times this new medicine is being given to people. Scientists want to understand how BBT001 affects the body, what dose is best, and if it has any side effects or safety concerns. The study will involve both healthy volunteers and adults who have eczema. The aim is to gather important information to see if this new medicine has the potential to help people with eczema in the future.
En un coup d'œil
De quoi parle cette étude ?
This study is about a new medicine called BBT001, which is being investigated as a possible treatment for a common skin condition known as atopic dermatitis, or eczema. Eczema can make your skin red, itchy, dry, and cracked, and it can be uncomfortable and frustrating for many people.
Because BBT001 is a new medicine, this study is a very early step in its development. It's called a 'Phase 1' study. This means it's one of the first times the medicine will be given to people. The main goals at this stage are to understand how the medicine behaves in the human body, how much is needed, and to check if it's safe. It will involve both healthy people and adults who have eczema, allowing researchers to compare how the medicine affects different groups.
If this initial study shows that BBT001 is safe and acts in the body as expected, it could then move on to bigger studies. These larger studies would aim to see if the medicine actually helps improve eczema symptoms. So, this first step is crucial for deciding if BBT001 has the potential to become a useful treatment option for people living with eczema in the future.
Points clés
- This is an early study of a new eczema medicine, BBT001.
- It aims to find out if BBT001 is safe and how it works in the body.
- The study includes both healthy adults and adults with eczema.
- Participation involves clinic visits and careful monitoring.
- Vous pouvez vous retirer de l'étude à tout moment.
- It's not yet known if BBT001 will be an effective treatment.
Qui peut être éligible ?
To join this study, you need to be an adult, aged 18 years or older – there's no upper age limit. The study is open to both men and women.
Part of the study will involve healthy volunteers, meaning people who don't have eczema or other significant health problems that could affect the study results. Another part will involve adults who have been diagnosed with atopic dermatitis (eczema).
The research team will have specific health checks and criteria to make sure it's safe for you to take part and that the study results are clear. These will involve looking at your overall health and any other medications you might be taking.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Avez-vous 18 ans ou plus ?
- Do you have atopic dermatitis (eczema), or are you a healthy adult?
- Êtes-vous en mesure d'assister à des visites régulières à la clinique ?
- Are you comfortable potentially taking an experimental medicine?
- Do you understand that this is a research study, not a guaranteed treatment?
En quoi consiste la participation ?
If you decide to take part in this study, you will have several visits to the clinic. During these visits, the study team will carry out health checks, which might include blood tests, urine tests, physical examinations, and measuring your vital signs like blood pressure and heart rate. You will be given the study medicine, BBT001, according to a specific schedule, and the team will closely monitor how your body reacts.
Depending on the specific part of the study you join, you might need to stay at the clinic for certain periods or attend regular follow-up appointments. The total time you'd be involved in the study could vary, but the team will explain the full schedule of visits and assessments to you before you agree to participate. You'll also be asked to keep a diary or record at home about any symptoms or how you're feeling.
Risques et avantages potentiels
Emplacements (1)
- —Non vérifiéPologne
Questions fréquentes
What is atopic dermatitis or eczema?
It's a common skin condition that makes your skin red, itchy, dry, and sometimes cracked. It often flares up and then settles down.
What does 'Phase 1' study mean?
This is a very early stage of testing a new medicine. It means it's one of the first times it's given to people, mainly to check if it's safe and how it works in the body.
Will this medicine cure my eczema?
It's too early to say if BBT001 will cure eczema. This study is mainly about safety and understanding the medicine, not about whether it cures the condition.
Dois-je payer pour participer à l'étude ?
No, you don't have to pay to join a clinical trial. All study-related care and medicines are provided free of charge.
Puis-je quitter l'étude si je change d'avis ?
Yes, you can leave the study at any time, for any reason, without it affecting your medical care.
Comment en savoir plus
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.